used in classic Chinese, Ayurvedic, and Thai medicine. Conolidine could stand for the beginning of a fresh era of chronic pain management. It's now becoming investigated for its outcomes within the atypical chemokine receptor (ACK3). In the rat model, it had been uncovered that a competitor molecule binding to ACKR3 resulted in inhibition of ACKR3�